Archive for the ‘Viruses’ Category

Ivermectin Beats Out 9 Other Meds For Treating Omicron, Study Confirms

**UPDATE Feb. 17, 2022**

True to form, the day after this information about ivermectin is disseminated, Medpage Today comes out with yet another trash piece on ivermectin.  Mainstream media is also guilty.  Rather than discussing solid data, science, and the fact it has worked even on the most severe cases, the article focuses on a singular doctor on twitter who states FLCCC’s therapies for Long COVID is like “throwing spaghetti against the wall,” as well as, “Throwing 20 medications (9 are prescription) at a problem with minimal (or no) evidence is irresponsible. As we will see, this is both unethical & likely harmful.” ~ Nick Mark, MD

Lyme/MSIDS patients and Lyme literate doctors take note of this attack because the same thing has been said about effective treatments for tick-borne illness due to the fact pathogens cause severe immune dysfunction and can affect every organ in the human body – similarly to COVID.  FLCCC has figured this out and is addressing multiple issues the body is contending with when infected with COVID. 

Go here for today’s summit called “Gold Standard COVID Science in Practice.”

Go here to watch a short but crucial video on the effectiveness of ivermectin and HCQ by America’s Front-line Doctors (AFLDS).

https://childrenshealthdefense.org/defender/ivermectin-beats-meds-treating-omicron

Ivermectin Beats Out 9 Other Meds for Treating Omicron, Study Confirms

Researchers used computational analyses to evaluate the performance of 10 medications against the Omicron variant, finding ivermectin outperformed all of them, including nirmatrelvir (Paxlovid), a new drug from Pfizer that has cost taxpayers $5.29 billion and costs $529 per course of treatment.

Newest ivermectin study showed best results against COVID.

Story at-a-glance: 

  • Researchers used computational analyses to evaluate the performance of 10 medications against the Omicron variant, finding that ivermectin outperformed all of them, including nirmatrelvir (Paxlovid) a new drug from Pfizer that has cost taxpayers $5.29 billion and costs $529 per course of treatment.
  • Ivermectin lowers the viral load by inhibiting replication, reduces infection by 86% when used preventively, speeds recovery, protects against organ damage, lowers the risk of hospitalization and death and costs between $48 and $95 for a course of treatment depending on your location.
  • Early treatment lowers your risk of long COVID, which includes physical and mental health conditions. According to cardiologist Dr. Peter McCullough, 50% of those sick enough to be hospitalized have symptoms of long COVID.
  • Africa has a lower number of cases, severity of disease, hospitalizations and deaths than other areas of the world, which may be due to using prophylactic medications for endemic infections that have successfully treated COVID.

At nearly no other time in history has there been this level of fear generated across the world as experienced thus far in 2020 and 2021. The depth and breadth of the strategies used to stoke those fears have been overwhelming.

Emergency use authorizations for drugs that have not proven to be effective in trials, public mask mandates for which there is no scientific evidence and the suppression and censorship of health information has boosted public fear over a viral illness with a survival rate of over 99%.

Unfortunately, many of the early effective treatment strategies that can be used at home have also fallen victim to censorship. Ivermectin is one of those strategies. In a computational analysis of the Omicron variant against several therapeutic agents, data show that ivermectin had the best results.

Yet, as you look objectively at what’s been happening across the world, the fear being generated is not one-sided. The suppression of information by corporations, government agencies and the pharmaceutical industry is one indication of their concern and how far they’re willing to go to ensure the level of fear remains high enough to manipulate behavior.

Consider the statistics from the Centers for Disease Control and Prevention. In 2019, 4.6% of the U.S. population was diagnosed with heart disease. The population at the end of 2019 was 328,239,523.

This means there were 15,099,018 people with heart disease in the U.S. in 2019. There were 696,962 people who died that year from heart disease, which is a death rate of 4.6%.

This is 20 times greater than the death rate from COVID-19. Yet these same agencies were not lobbying for mandates against soda or sugar-laden foods — they weren’t banning smoking and they weren’t mandating exercise — all heart disease risk factors.

The censorship and suppression of information has hobbled early treatment of COVID-19 in many western nations. Through 2020, public health experts and the mainstream media warned against the use of hydroxychloroquine and ivermectin.

Both are on the World Health Organization’s list of essential drugs, but the benefits have been ignored by public health officials and buried by the media.

Newest ivermectin study showed best results against COVID

This study on Cornell University’s preprint website has not yet been peer-reviewed. Researchers used a computational analysis to look at the Omicron variant, which has demonstrated a lower clinical presentation and lower hospital admission rates.

After having retrieved the complete genome sequence and collecting 30 variants from the database, the researchers analyzed 10 drugs against the virus, including:

Binding energy of promising drugs
Binding energy of promising drugs against main protease of Omicron variant.

The researchers found that each of the drugs had some degree of effectiveness against the virus and most were currently in clinical trials. They used molecular docking to find that the mutations in the Omicron variant didn’t significantly affect the interaction between the drugs and the main protease.

An analysis of all 10 drugs found that ivermectin was the most effective drug candidate against the Omicron variant. The testing included Nirmatrelvir (Paxlovid), which is the new protease inhibitor for which the U.S. Food and Drug Administration (FDA) provided an emergency use authorization against COVID in December 2021.

In other words, Pfizer released a new drug which cost the U.S. taxpayers $5.29 billion or $529 per course of treatment and which received an EUA despite the availability of a similar drug that has proven to be more effective and is cheaper.

How ivermectin works

Ivermectin is best known for its antiparasitic properties. Yet, the drug also has antiviral and anti-inflammatory properties. Studies have shown that ivermectin helps to lower the viral load by inhibiting replication.

A single dose of ivermectin can kill 99.8% of the virus within 48 hours.

A meta-analysis in the American Journal of Therapeutics showed the drug reduced infection by an average of 86% when used preventively. An observational study in Bangladesh evaluated the effectiveness of ivermectin as a prophylaxis for COVID-19 in health care workers.

The data showed four of the 58 volunteers who took 12 mg of ivermectin once a month for four months developed mild COVID symptoms as compared to 44 of the 60 health care workers who declined the medication.

Ivermectin has also been shown to speed recovery, in part by inhibiting inflammation and protecting against organ damage. This pathway also lowers the risk of hospitalization and death. Meta analyses have shown an average reduction in mortality that ranges from 75% to 83%.

Additionally, the drug also prevents transmission of SARS-CoV-2 when taken before or after exposure. Added together, these benefits make it clear that ivermectin could all but eliminate this pandemic.

Early intervention lowers long COVID and hospitalization

Some people who have had COVID-19 seem to be unable to fully recover and complain of lingering symptoms of chronic fatigue. Others struggle with mental health problems.

One study, in November 2020, found 18.1% of people who had COVID-19 received their first psychiatric diagnosis in the 14 to 90 days after recovery. Most commonly diagnosed conditions were anxiety disorders, insomnia and dementia.

These symptoms have come to be called long COVID, long-haul COVID, post-COVID syndrome, chronic COVID or long-haul syndrome. They all refer to symptoms that persist for four more weeks after an initial COVID-19 infection.

According to Dr. Peter McCullough (5:43), board-certified internist and cardiologist, 50% of those who have been sick enough to be hospitalized will have symptoms of long COVID:

“So, the sicker someone is, and the longer the duration of COVID, the more likely they are to have long COVID syndrome. That’s the reason why we like early treatment. We shorten the duration of symptoms and there’s less of a chance for long COVID syndrome.”

Some of the common symptoms of long COVID include shortness of breath, joint pain, memory, concentration or sleeping problems, muscle pain or headache and loss of smell or taste.

According to McCullough (6:05), a paper presented by Dr. Bruce Patterson at the International COVID Summit in Rome, Sept. 11 to 14, 2021:

“… showed that in individuals who’ve had significant COVID illness, 15 months later the s1 segment of the spike protein is recoverable from human monocytes. That means the body literally has been sprayed with the virus and it spends 15 months, in a sense, trying to clean out the spike protein from our tissues. No wonder people have long COVID syndrome.”

It should come as no surprise that studies have also confirmed that early intervention improves mortality and reduces hospitalizations. Perhaps one of the greatest crimes in this whole pandemic is the refusal by reigning health authorities to issue early treatment guidance.

Instead, they’ve done everything possible to suppress remedies shown to work. Patients were simply told to stay home and do nothing. Once the infection had worsened to the point of near-death, patients were told to go to the hospital, where most were routinely placed on mechanical ventilation — a practice that was quickly discovered to be lethal.

However, as the featured study and others have demonstrated, ivermectin is one of the successful treatment protocols that can be used against SARS-CoV-2.

Africa has lowest case and death rate, likely from ivermectin

Across the world, countries have taken different approaches to address the spread of the virus. The steps taken in Africa varied depending on the country, yet the infection and death rates were relatively stable and low across the continent.

In the last year there have been reports of small areas in the world where the number of infections, deaths or case-fatality rates have been significantly lower than the rest of the world. For example, India’s Uttar Pradesh State reported a recovery rate of 98.6% and no further infections.

However, the entire continent of Africa appears to have sidestepped the massive number of infections and deaths predicted for these poorly funded countries with overcrowded cities. Early estimations were that millions would die, but that scenario has not materialized.

The World Health Organization has called Africa “one of the least affected regions in the world.”

There are several factors that may influence the infection rate in Africa. A study from Japan (1.25) demonstrates that after just 12 days that doctors were allowed to legally prescribe ivermectin to their patients, the cases dropped dramatically.

The chairman of the Tokyo Medical Association had noticed the low number of infections and deaths in Africa, where many use ivermectin prophylactically and as the core strategy to treat onchocerciasis, a parasitic disease also known as river blindness.

More than 99% of people infected with river blindness live in 31 African countries.

In addition to ivermectin use in Africa, other medications are also commonly available, such as hydroxychloroquine and chloroquine, which have long been used in the treatment and prevention of malaria, also endemic in Africa.

In America, Dr. Vladimir Zelenko has published successful results using hydroxychloroquine and zinc against COVID-19.

Finally, Artemisia annua, also known as sweet wormwood, is an herb used in combination therapies to treat malaria. It was used in traditional Chinese medicine for more than 2,000 years to treat fever.

Today artemisinin, a metabolite of Artemisia, is the current therapeutic option for malaria. The plant has also been studied since the 2003 SARS outbreak for the treatment of coronaviruses, with good results.

In other words, whether by design or default, the medications that have proven to be successful against the virus are commonly used in Africa for other health conditions.

While Pfizer tests the short- and long-term effects of a genetic experiment on Israel’s population, it appears one continent has demonstrated administration of a 30-year-old, inexpensive drug with a known safety profile could reduce the cases, severity and mortality from this infection.

The question that must be asked and answered to get to the bottom of this plandemic is what is blinding mainstream media, government agencies, public health experts, medical associations, doctors, nurses and your next-door neighbor from recognizing and speaking out in support of science?

Originally published by Mercola.

The views and opinions expressed in this article are those of the authors and do not necessarily reflect the views of Children’s Health Defense.

© [2/16/22] Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.

_________________

**Comment**

Dr. Robert Califf, head of FDA under the Obama administration, is back as head of the FDA. Under his watch, he helped Big Pharma reap in record profits and sales and shielded them from any liability due to the opioid crisis. An FDA exec was taped by Project Veritas proving that the FDA is utterly controlled by Big Pharma. The fraud, collusion, and conflicts of interests are all exposed, plain as day, yet the lawlessness continues.

For more:

It’s gotten so bad, state attorney generals have had to call out the FDA, CDC, Fauci, and the media for ‘fueling confusion and misinformation’ by interfering with the treatment of COVID patients.  Both Nebraska and Oklahoma doctors are now free to prescribe off-label medications such as ivermectin and HCQ for COVID without fear of disciplinary action from corrupt groups like the AMA and state medical boards.

This legal action needs to happen in each and every state in the U.S.

Category:

Treatment, Viruses

FDA Exec: ‘Biden Wants to Inoculate As Many People As Possible’ & ‘Almost a Billion Dollars a Year Going into FDA’s Budget from the People We Regulate’. Califf to Head FDA: Corruption Continues…

What you are about to read will make perfect sense when you know that two high-level regulatory officials with the FDA involved in vaccine oversight accepted jobs at Moderna just months after signing off on the licensure of the company’s COVID-19 vaccine, according to a British Medical Journal (BMJ) investigation. This is not the first time issues have been raised with the FDA’s “revolving door”—a concept defined in an October 2005 paper by the Revolving Door Working Group (RDWG) as the “movement of individuals back and forth between the private sector and the public sector.”

http://  Approx. 7 Min

Feb. 15, 2022

FDA Exec on Camera Reveals Future COVID Policy “Biden Wants To Inoculate As Many People As Possible”

FDA Executive Officer, Christopher Cole:

“You’ll have to get an annual shot [COVID vaccine].  I mean, it hasn’t been formally announced yet ‘cause they don’t want to, like, rile everyone up.”

  • Cole on President Joe Biden: “Biden wants to inoculate as many people as possible.”
  • Cole on plans to approve vaccine for toddlers: “They’re not going to not approve [emergency use authorization for children five years old or less].”
  • Cole on pharmaceutical companies: “There’s a money incentive for Pfizer and the drug companies to promote additional vaccinations.”
  • Cole on the financial incentive for pharmaceutical companies: “It’ll be recurring fountain of revenue. It might not be that much initially, but it’ll be recurring — if they can — if they can get every person required at an annual vaccine, that is a recurring return of money going into their company.”
  • FDA Official Statement: “The person purportedly in the video does not work on vaccine matters and does not represent the views of the FDA.”
  • [WASHINGTON, D.C. – Feb. 15, 2022] Food and Drug Administration [FDA] Executive Officer, Christopher Cole, inadvertently revealed that his agency will eventually announce that annual COVID-19 vaccinations will become policy.
  • Cole is an Executive Officer heading up the agency’s Countermeasures Initiatives, which plays a critical role in ensuring that drugs, vaccines, and other measures to counter infectious diseases and viruses are safe. He made the revelations on a hidden camera to an undercover Project Veritas reporter.
  • Cole indicates that annual COVID-19 shots isn’t probable — but certain. When pushed on how he knows an annual shot will become policy, Cole states, “Just from everything I’ve heard, they [FDA] are not going to not approve it.”
  • The footage, which is part one of a two-part series on the FDA, also contains soundbites from Cole about the financial incentives pharmaceutical companies like Pfizer have to get the vaccine approved for annual usage. “It’ll be recurring fountain of revenue,” Cole said in the hidden camera footage. “It might not be that much initially, but it’ll recurring — if they can — if they can get every person required at an annual vaccine, that is a recurring return of money going into their company.”
  • Perhaps the most explosive part of the footage is the moment where Cole brazenly talks about the impact that an Emergency Use Authorization has on overcoming the regulatory concerns of mandating vaccines on children. 

“They’re all approved under an emergency just because it’s not as impactful as some of the other approvals,” Cole said when asked if he thought there was “really an emergency for kids.”

Cole, who claims his role with the FDA is to ensure the agency uses a framework of safety, security, and effectiveness as a part of its preparedness and response protocol, specifically cited concerns over “long term effects, especially with someone younger.”

http://  Approx. 8 Min

FDA Executive Officer Exposes Close Ties Between Agency and Pharmaceutical Companies:

‘Almost a Billion Dollars a Year Going into FDA’s Budget from the People we Regulate’

• FDA Executive Officer Chris Cole: “The drug companies, the food companies, the vaccine companies. So, they pay us hundreds of millions of dollars a year to hire and keep the reviewers to approve their products.”
• Cole on FDA fees: “Congress approved user fees for [the] FDA. Basically, we charge the industry millions of dollars in order to hire more drug reviewers and vaccine reviewers which will speed up the approval process. So, they [pharmaceutical companies] make more money.”
• Cole: “They [FDA] tone down the impact of the user fees on their operations because they know they’re dependent on the drug companies, and the vaccine companies, and these other companies for their agency to operate.”
• Cole on blowing the whistle: “There’s not an incentive to speak out in government, surprisingly. You would think there would be, but there’s not. It’s better just to just not say anything and just ignore it.”
• Cole on retaliation in government: “You’ll be marked from getting other jobs because another office is not going to want to hire you if you’ve spoken out about something, right or wrong. They don’t look at what you’ve spoken out about. They’re just not willing to- government’s about rocking the boat and they don’t want to- which is the problem I have with- one of the problems I have with government is, like, they don’t like people rocking the boat, for right or wrong, at all costs. They want to hire a safe person that can do the job but doesn’t necessarily- is a great hire.”

[WASHINGTON, D.C. – Feb. 16, 2022] Project Veritas published Part Two of its series on the FDA on Wednesday night which featured FDA Executive Officer, Christopher Cole, speaking about the inner workings of the agency including the FDA’s conflicts of interest, overspending, and why it’s hard for those within the agency to speak out on such abuses.

In the footage, Cole talks about the impact that pharmaceutical companies have on the agency including the process for approving drugs.

“A long time ago, Congress approved user fees for [the] FDA. Basically, we charge the industry millions of dollars in order to hire more drug reviewers and vaccine reviewers, which will speed up the approval process, so they make more money,” Cole says in the hidden camera footage.

He then reveals that the FDA tones down the impact that these user fees have on the agency’s operations because, “they’re dependent on the drug companies, and the vaccine companies and these other companies for their agency to operate.”

The incendiary footage, which features Cole talking about how the additional money the FDA brings in “gets banked” to be spent on “whatever you can, whether it’s right or wrong,’’ also features Cole discussing reasons why it’s difficult for anyone in government to speak out about practices he sees as “probably excessive.”

“I don’t think there’s enough people saying — they’re, like, ‘Look, that’s fine, but that’s not right. So, we’re not going to charge that.’ You don’t want to be that person. You’re not going to have a long shelf life in the agency if you’re always that person,” Cole said.

“There’s not an incentive to speak out in government, surprisingly. You would think there would be, but there’s not. It’s better just to just not say anything and just ignore it. The whistleblower, well, it’s high-profile whistleblower statutes and everything, that’s kind of ridiculous,” Cole said before adding “it’s better to just stay quiet and accept.”

Cole’s LinkedIn page lists him as an Executive Officer within the agency’s Countermeasures Initiatives, which plays a critical role in ensuring that drugs, vaccines, and other measures to counter infectious diseases and viruses are safe. He made these revelations on a hidden camera to an undercover Project Veritas reporter.

A spokesperson for FDA issued a statement yesterday saying, “The person purportedly in the video does not work on vaccine matters and does not represent the views of the FDA.”

This statement appears to contradict a phone call released Wednesday afternoon by Project Veritas wherein Cole reiterated, during the conversation with Project Veritas Founder and CEO, James O’Keefe, that he is “a manager in the office that helps oversee the approval of the COVID vaccines for emergency approval.”

Please see below in the link that indeed, Dr. Robert Califf was voted in to head the FDA.  We can only expect the corruption to continue under his reign.

For more:

Apparently Robert Califf did such a good job of helping Big Pharma shield themselves from any liabilities due to the opioid crisis that destroyed the lives of so many Americans while he was head of the FDA under President Obama, that he is being brought back to lead the FDA again to help Big Pharma continue growing in record profits and sales as they get ready to expand the market for the COVID-19 gene-altering shots by having Americans get vaccinated every year, along with the already profitable flu shots.

While he was approved to lead the FDA by the Senate in an overwhelming vote of support with an 89-4 Senate vote on his confirmation in 2016, this time around he barely survived the confirmation vote which was 50-46, facing bi-partisan opposition to his confirmation.

Senators Joe Manchin and Republican Senator Mike Braun from Indiana paired up to write an op-ed piece published at USA Today to voice their opposition to Califf’s confirmation as head of the FDA.

Since OxyContin was approved by the Food and Drug Administration in 1995, more than 500,000 Americans have died from overdoses related to opioids and synthetic opioids.

Nearly three decades later, more than 101,000 Americans – over 1,500 West Virginians and nearly 2,500 Hoosiers – died between June 2020 and June 2021. It’s clear that not much has changed in the way the FDA approves and manages these highly addictive, destructive drugs killing Americans at an astonishing rate.

In fact, it has become increasingly clear that the FDA has stood by, and even enabled, the pharmaceutical industry’s decision to choose profits over American lives.

High overdose rates, not enough treatment facilities

Many families across the United States have been impacted by the drug epidemic that continues to ravage our nation. In our beloved states of West Virginia and Indiana, our communities continue to face disproportionately high overdose rates, with not nearly enough treatment facilities to care for our neighbors in need.

However, instead of reining in opioid prescribing, the agency in charge of regulating these substances continues to approve even more deadly opioids. It is crystal clear that the FDA has not done enough to address the drug epidemic ravaging our nation.

Given the dire situation facing our communities, it makes absolutely no sense to install a candidate who has already led the FDA in its most senior position but failed to address this crisis in any meaningful way.

A poor record on opioids

The current FDA commissioner nominee, Dr. Robert Califf, has significant ties to the pharmaceutical industry, and his leadership of the FDA would take us backward, not forward. His nomination is an insult to the many families and individuals who have had their lives changed forever as a result of addiction.

During Dr. Califf’s previous tenure as FDA commissioner, drug-related overdoses went up, a clear indicator the FDA hadn’t made any necessary, meaningful changes to address the crisis facing our country. In 2016, then-Commissioner Califf announced the FDA’s plan to overhaul its opioid policies.

But between 2016 and 2017, the FDA approved five new opioids and only removed a single opioid from the market. Dr. Califf also commissioned a report on opioids, but the report failed to review the flawed enriched enrollment randomized withdrawal (EERW) methodology used to approve new opioids.

Reports have also indicated that Dr. Califf intends to keep Dr. Janet Woodcock on board as a senior adviser if confirmed to lead the FDA. During her tenure at the FDA, Dr. Woodcock has directly overseen the approval of numerous highly addictive drugs to market.

She also decided to ignore the advice of an FDA advisory committee when she chose to approve Zohydro, a questionable pure hydrocodone drug with strong risk of overdose and death.

The pharmaceutical industry has benefitted from the status quo at the FDA under the leadership of Dr. Califf and Dr. Woodcock, and the American people have suffered for it. (Full article.)

Category:

Activism, vaccines, Viruses

Autopsy in Two Adolescents Following 2nd COVID Shot: Catecholamine-Mediated Stress (Toxic) Cardiomyopathy

https://meridian.allenpress.com/aplm/article/doi/10.5858/arpa.2021-0435-SA/477788/Autopsy-Histopathologic-Cardiac-Findings-in-Two

February 14 2022

Autopsy Histopathologic Cardiac Findings in Two Adolescents Following the Second COVID-19 Vaccine Dose

James R. Gill, MD;
Randy Tashjian, MD;
Emily Duncanson, MD
 
 
Arch Pathol Lab Med (2022)
https://doi.org/10.5858/arpa.2021-0435-SA
 
Context.– Myocarditis in adolescents has been diagnosed clinically following the administration of the second dose of an mRNA vaccine for coronavirus disease 2019 (COVID-19).Objective.– To examine the autopsy microscopic cardiac findings in adolescent deaths that occurred shortly following administration of the second Pfizer-BioNTech COVID-19 dose to determine if the “myocarditis” described in these instances has the typical histopathology of myocarditis.

Design.– Clinical and autopsy investigation of two teenage boys who died shortly following administration of the second Pfizer-BioNTech COVID-19 dose.

Results.– The microscopic examination revealed features resembling a catecholamine-induced injury, not typical myocarditis pathology.

Conclusions.– The myocardial injury seen in these post-vaccine hearts is different from typical myocarditis and has an appearance most closely resembling a catecholamine-mediated stress (toxic) cardiomyopathy. Understanding that these instances are different from typical myocarditis and that cytokine storm has a known feedback loop with catecholamines may help guide screening and therapy.

__________________

**Comment**

More proof that these injections are TOXIC.  The following pictures after getting the shots says it all:

For more:

If you haven’t signed the petition yet, and contacted your governor and local legislators that COVID injections must be voluntary, please do:  https://standforhealthfreedom.com/action/covid-vaccines-must-be-voluntary/

For a recap on where we stand:

  • The FDA and Pfizer had to hit pause on their plan to push Covid shots into our youngest and most vulnerable children because of an overwhelming outpouring of opposition.
  • In Missouri, health advocates stopped the confirmation of a Public Health Director who had undisclosed ties to a company pushing vaccine passports.
  • SCOTUS is holding the line when agencies with no ties to our communities try to tell us how to make choices in our daily lives.
  • The White House wants to place itself directly into our schools, our homes, our jobs, and our healthcare. But the people are saying No!
  • Finally, the “misinformation” health advocates were sharing is now becoming mainstream news. The narrative is changing because truth was spoken to power and the truth will prevail.
  • This year is crucial for the future of our country and for our children. In this mid-term election year, the people WILL make their voices heard. Make sure you are registered and that you vote in your primaries.
  • The antidote to federal overreach into our communities is…a strong community. Source

Lastly, watch this 10 minute speech at a recent protest. She hits the nail on the head – powerfully.

http://

Feb. 15, 2022

Category:

research, vaccines, Viruses

And An Honorary Award Goes to Dr. Campbell

https://popularrationalism.substack.com/p/john-campbells-list-of-studies-

John Campbell’s List of Studies On Natural Immunity

He is Amazing, and Should Be Given an Honorary Everything.

I’ve watched John Campbell review all things related to COVID-19 since the beginning of the pandemic. He has proven to be 100% unbiased and willing to represent the evidence as well as he understands it.

His first video on Coronavirus aired Jan 26, 2020. He now has 1.2M viewers on YouTube – with endless videos, one or two per day, he has covered nearly every aspect of COVID-19 and SARS-CoV-2.

In this video, he reviews the scientific evidence of natural immunity, which he says “seems good and long-lasting and cheap, lots of evidence below.”

He expansion collection of links and annotations are provided below for those looking for resources on evidence of natural immunity.

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(21)00676-9/fulltext

Biological studies

Dan et al (2021) Science, Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection.

https://www.science.org/doi/full/10.1126/science.abf4063

95% of participants tested retained immune memory at about 6 months after having COVID-19

More than 90% of participants had CD4+ T-cell memory at 1 month,

and 6–8 months after having COVID-19

Wang et al (2021) Science, Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants

https://www.science.org/doi/full/10.1126/science.abh1766

Previous SARS-CoV-2 infection, with an ancestral variant produce antibodies that cross-neutralize emerging variants of concern with high potency

Epidemiological studies

Hansen et al (2021) Lancet, Assessment of protection against reinfection with SARS-CoV-2 among 4 million PCR-tested individuals in Denmark in 2020: a population-level observational study

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00575-4/fulltext

People who had had COVID-19 previously were around 80·5% protected against reinfection

Pilz et al (2021) European Journal of Clinical Investigation, SARS-CoV-2 re-infection risk in Austria

https://onlinelibrary.wiley.com/doi/full/10.1111/eci.13520

Sheehan et al (2021) Clinical Infectious Diseases, Reinfection rates among patients who previously tested positive for COVID-19: a retrospective cohort study

https://academic.oup.com/cid/article/73/10/1882/6170939

Shrestha et al (2021) Preprint, Necessity of COVID-19 vaccination in previously infected individuals

https://www.medrxiv.org/content/10.1101/2021.06.01.21258176v3

Retrospective cohort study in the USA,

People who had had COVID-19 previously were 100% protected against reinfection

Gazit et al (2021) Preprint, Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections

https://www.medrxiv.org/content/10.1101/2021.08.24.21262415v1

Kojima et al (2021) Preprint, Incidence of severe acute respiratory syndrome coronavirus-2 infection among previously infected or vaccinated employees

https://www.medrxiv.org/content/10.1101/2021.07.03.21259976v2

Laboratory staff routinely screened for SARS-CoV-2, people who had had COVID-19 previously were 100% protected against reinfection

Clinical studies

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00675-9/fulltext

Large, multicenter, prospective cohort study

Previous COVID-19 diagnosis, 84% decreased risk of infection

Letizia et al (2021) Lancet, Respiratory Medicine, SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study

https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(21)00158-2/fulltext

Prospective cohort of US Marines.

Seropositive young adults were 82% protected against reinfection

Adnan et al (2021) Clinical Infectious Diseases, Reinfection With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Patients Undergoing Serial Laboratory Testing

https://academic.oup.com/cid/article/74/2/294/6251701

N = 9,119, serial tests

Reinfection rates, 0.7%

So

Risk of repeat SARS-CoV-2 infection decreased by 80·5–100% among those who had had COVID-19

Protection from reinfection is strong and persists for more than 10 months of follow-up, (Hansen et al 2021 Lancet)

Turner, et al Nature, SARS-CoV-2 infection induces long-lived bone marrow plasma cells in humans

https://www.nature.com/articles/s41586-021-03647-4?amp%3Bcode=7bafb609-23c2-4665-804b

Madhuumita et al, Plos One, T cell response to SARS-CoV-2 infection in humans: A systematic review

https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0245532

SARS-CoV-2 infection induces specific and durable T-cell immunity,

Nina et al, (2020) Nature, SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls

https://www.nature.com/articles/s41586-020-2550-z?flip=true

Memory B-cell response to SARS-CoV-2 evolves between 1·3 and 6·2 months after infection, which is consistent with longer-term protection

Some people who have recovered from COVID-19 might not benefit from COVID-19 vaccination

https://www.medrxiv.org/content/10.1101/2021.04.20.21255670v1

One study found that previous COVID-19 was associated with increased adverse events following vaccination with Pfizer

https://www.journalofinfection.com/article/S0163-4453(21)00277-2/fulltext

In Switzerland, proof of recovered infection, in the past 12 months are considered equally protected as fully vaccinated,

https://www.schengenvisainfo.com/news/switzerland-plans-to-extend-covid-certificate-requirement-until-mid-november/

Thank you, John!

___________________

**Comment**

I attempted to find a graphic of natural immunity but Google wouldn’t let me.  While not shocking, this is quite telling as natural immunity has been acknowledged from the beginning of time but is being downplayed, ignored, and frankly rewritten as only coming from “vaccines.”  This is intentional and you need to be aware of it.

This article explains how natural immunity to coronavirus lasts a year and perhaps a life-time, and that cells that retain a memory of the virus persist in the bone marrow and may churn out antibodies whenever needed. Natural immunity is long lasting, robust, and better than vaccines.  Further, effective treatments makes the need for a vaccine null and void, which of course is why they are ridiculing and attacking doctors who are educating others about these treatments.

  • Recently a Johns Hopkins professors states to “ignore the CDC” due to their refusal to recognize natural immunity from previous infection. The WHO also recently changed the definition of herd immunity to now only come from vaccines, essentially rewriting hundreds of years of scientific understanding.
  • There is ample evidence that those who have already had COVID should NOT get “vaccinated.” Dr. Hooman Noorchashm has repeatedly warned the FDA that “clear and present danger” exists for those who have had COVID-19 and subsequently get vaccinated due to viral antigens that remain in the body after a person is naturally infected; the immune response reactivated by the COVID-19 vaccine may trigger inflammation in tissues where the viral antigens exist. An international survey of 2,002 people found that people who had previously had COVID-19 experienced “significantly increased incidence and severity” of side effects after the COVID-19 vaccine
  • It’s important to remember that COVID injections are part of a grand experiment where final data is unknown. These are experimental, fast-tracked injections that do not stop transmission or infection and have not undergone rigorous testing, have already proven to be the most dangerous injections in the history of VAERS.

Category:

vaccines, Viruses

Reactivated Infections: A Possible Piece of the Chronic Illness Puzzle

https://www.globallymealliance.org/blog/reactivated-infections-a-possible-piece-of-the-chronic-illness-puzzle

Reactivated Infections: A Possible Piece of the Chronic Illness Puzzle

by Jennifer Crystal on January 28, 2022

<span id="hs_cos_wrapper_name" class="hs_cos_wrapper hs_cos_wrapper_meta_field hs_cos_wrapper_type_text" style="" data-hs-cos-general-type="meta_field" data-hs-cos-type="text" >Reactivated Infections: A Possible Piece of the Chronic Illness Puzzle</span>
Did you know that old infections can get reactivated due to COVID-19 or tick-borne illness?

For almost two years now, comparisons have been drawn between long-haul COVID-19 and long-haul tick-borne illness. In addition to many overlapping symptoms including persistent fatigue, brain fog, and pain, questions about the cause of these long-haul symptoms are also similar: Is it ongoing infection? Is it a dysregulated immune system? Is it inflammation? The answers may not be mutually exclusive.

There may also be another factor at play: old infections that get reactivated as a result of acute COVID-19 or tick-borne illness.

Many of us have dormant infections in our bodies. Those of us who had chicken pox as kids still carry varicella-zoster virus. For most of us, that virus stays dormant forever, but for some—particularly those who are immunocompromised or who suffer extreme stress—the virus can reactivate later as shingles.[i]

Another example is Epstein-Barr virus, which causes mononucleosis. While 95% of adults probably carry this virus, for many it is always dormant, and they don’t even know they have it [ii]. Others, like myself, are not so lucky. My own case of infectious mononucleosis dragged on, slipping into chronic active Epstein-Barr virus. Though my acute symptoms of swollen glands and sore throat cleared up, fatigue, and low-grade fever persisted for two years. I later learned that my body could not adequately fight Epstein-Barr because I also had underlying, untreated tick-borne infections including Lyme disease, babesiosis, ehrlichiosis, and possible bartonella. I spent another several years battling those tick-borne illnesses into remission, including one shattering relapse. So focused was on I treating those infections—which also caused fatigue and fever—that I sometimes forgot I had Epstein-Barr virus.

But the body does not forget. A few years ago, after a particularly stressful period in my life, I had a minor flare-up of symptoms. Though not bedridden again, I was more tired than usual. Long-gone joint and muscle aches returned. I panicked that my tick-borne illnesses were back in full force. And while they were reactivated a bit, tests revealed that what was really flaring was Epstein-Barr virus. I’d forgotten that the virus that had originally sent me to bed all those years ago could come back, too.

That episode was an important wake-up call to me, and I hope it will be for other Lyme warriors too: not all symptoms we have are Lyme-related. We have to remember what else our bodies harbor, what else can reactivate when our immune systems are down.

On the flip side, we also have to remember that Lyme can be a relapsing illness, as my doctor describes it. Research proves that Lyme bacteria can persist after antibiotic treatment. This means that the bacteria can lie dormant, and slowly start replicating at a later point, particularly if the body is under some kind of stress. “High level stress is like walking into a minefield of ticks,” my doctor once said. Stress can be external, like from a tough job situation or a hard breakup. It can also be physical, like from an acute illness such a cold or COVID-19.

Luckily, my own long-haul case of COVID-19 did not cause a flare-up of any of my underlying infections. My doctors hope this means that as I’ve grown healthier over the years, my body has become more resilient. But other COVID-19 long-haulers have experienced reactivation of other illnesses, like the patients described in “For These 17 COVID Long Haulers, Reactivated Viruses May Be to Blame” on verywellhealth.com.

For all of us long-haulers, it’s important that we don’t get tunnel vision about the illnesses we deal with on a day-to-day basis. We must also consider other, older infections in our bodies, and how they might impact recovery.

[i] https://www.verywellhealth.com/long-covid-latent-viral-reactivations-5205269?utm_source=facebook&utm_medium=social&utm_campaign=shareurlbuttons&fbclid=IwAR3FaE8sJJGxhShKcWzI3f0EKbkTml8QzQdnh742oVIsSsMLPlqnD4QXXlg#citation-5

[ii] Womack J, Jimenez M. Common questions about infectious mononucleosis. Am Fam Physician. 2015;91(6):372-376

Writer

Jennifer Crystal

Opinions expressed by contributors are their own. Jennifer Crystal is a writer and educator in Boston. Her work has appeared in local and national publications including Harvard Health Publishing and The Boston Globe. As a GLA columnist for over six years, her work on GLA.org has received mention in publications such as The New Yorker, weatherchannel.com, CQ Researcher, and ProHealth.com. Jennifer is a patient advocate who has dealt with chronic illness, including Lyme and other tick-borne infections. Her memoir about her medical journey is forthcoming. Contact her via email below.

Email: lymewarriorjennifercrystal@gmail.com

_______________

**Comment**

Many avoid stating it, but vaccines can also be a physical stress that can reactivate latent infections.  I’ve witnessed this personally in Lyme/MSIDS patients who have had symptoms come roaring back after getting a vaccine.  Vaccines are not without risk and for Lyme/MSIDS patients they pose a significant risk due to an already dysfunctional immune system and an overwhelming amount of inflammation.

Please see: 

Category:

Inflammation, Lyme, vaccines, Viruses